Medicine & Life Sciences
Amyloid
100%
Positron-Emission Tomography
82%
Alzheimer Disease
74%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
52%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
52%
Fluorodeoxyglucose F18
38%
Biomarkers
29%
Cognitive Dysfunction
26%
Atrophy
25%
Apraxias
23%
Neuroimaging
22%
Brain
22%
Aphasia
22%
Primary Progressive Aphasia
20%
White Matter
19%
Dementia
18%
Pathology
17%
Progressive Supranuclear Palsy
15%
Choline
11%
Temporal Lobe
11%
Cognition
10%
Gray Matter
10%
Head and Neck Neoplasms
10%
Magnetic Resonance Imaging
9%
Prostatic Neoplasms
9%
Tauopathies
8%
Single-Photon Emission-Computed Tomography
8%
Neoplasms
8%
Apolipoprotein E4
8%
Amyloidosis
8%
Population
8%
Recurrence
7%
Language
7%
Phenotype
7%
Frontotemporal Dementia
7%
Elderly
7%
Entorhinal Cortex
6%
Radiotherapy
6%
Autopsy
6%
Glucose
6%
Memory
6%
Parietal Lobe
6%
Frontotemporal Lobar Degeneration
6%
Amyloid Plaques
6%
Tomography
5%
Neck
5%
Cognitive Aging
5%
Diffusion Tensor Imaging
5%